Should we loosen up on ventricular rate control?

Mar 16, 2010 11:20 EDT


By showing that lenient ventricular rate control is as good as strict in AF, the RACE-2 trial is a real challenge to dogma. Have we been wrong all these years? How will these findings change your clinical practice?

See:

"Lenient" as good as "strict" ventricular rate control in permanent AF: RACE-2 trial





« Previous Post
NAVIGATING lessons: Design smaller trials with more biological plausibility
Mar 19, 2010 15:30 EDT Next post »
Mitral-clip in EVEREST II: A step forward
Mar 15, 2010 23:30 EDT



Your comments
Should we loosen up on ventricular rate control?
# 1 of 1
March 17, 2010 09:09 (EDT)
Guy W-S

Polypharmacy for atrial fibrillation in the elderly is a real problem.

 

This trial may help prevent patients taking multiple drugs when they don't need them.

 

I think I will  take the results on board and alter my practice and advice to local general practitioners who always seem to be concerned about a patients heart rate in atrial fibrillation.

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
Who's talking
Photo
Eric J Topol MD
Director, Scripps Translational Science Institute
The Gary and Mary West Chair of Innovative Medicine
Chief Academic Officer, Scripps Health
La Jolla, CA